Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News BD maintains recent strong momentum in second quarter of 2014

BD maintains recent strong momentum in second quarter of 2014

9th May 2014

BD has announced its financial results for the second quarter of 2014, during which it experienced year-on-year growth of 3.6 percent.

During the three months ending on March 31st 2014, the firm generated revenues of $2.07 billion (1.23 billion pounds), a strong performance that was driven by its medical segment and the continued improvement in its biosciences division.

Its performance outside the US demonstrated a more robust growth rate than its American division, while its six-month performance was also shown to be encouraging, with diluted earnings per share from continuing operations rising 2.9 percent to $2.82.

BD has reaffirmed its previously communicated currency-neutral revenue guidance range of 4.5 to 5.0 percent, based on the strength of these results.

Vincent Forlenza, chairman, chief executive officer and president of BD, said: "This consistent performance demonstrates the breadth of the growth drivers across our businesses and regions, and highlights the diversity of our portfolio."

This comes after the firm reported better-than-expected results for the first quarter of 2014, leading it to increase its targets for the full year.ADNFCR-8000103-ID-801719182-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.